Longitudinal associations between weight indices, cognition, and mental health from childhood to early adolescence ================================================================================================================== * Zhaolong Adrian Li * Mary Katherine Ray * Yueping Gu * Deanna M. Barch * Tamara Hershey ## Abstract Childhood obesity has been associated with lower cognitive performance and worse mental health in cross-sectional studies. However, it is unclear whether these findings extend longitudinally and in what causal direction. Using data from the Adolescent Brain Cognitive Development (ABCD) Study (maximum analytical n = 6671, 48.3% girls, 42.8% non-White), we examined how body mass index (BMI) at baseline (ages 9-11) relate prospectively to changes in cognition or psychopathology across the 2 years thereafter, and vice versa. Cognitive tests included the National Institutes of Health Toolbox Cognition Battery, Little Man Task of mental rotation, and Rey Auditory Verbal Learning Test. Psychopathology was assessed using caregiver-reported Child Behavior Checklist. Linear mixed models adjusted for sociodemographic and developmental covariates indicated that lower baseline performance on most cognitive tests was associated with greater longitudinal BMI gain (eg, 1 point lower than median on Picture Vocabulary corresponded to 0.012 kg/m2 [1.6%; 95% CI, 0.008 to 0.016 kg/m2] more annual BMI gain, *P*FDR < .001), whereas baseline BMI was unrelated to longitudinal changes in cognition (*P*FDR ≥ .12; including after considering practice effects). Greater broad-spectrum psychopathology at baseline was associated with increased BMI gain (eg, each endorsement of externalizing problems than none corresponded to 0.015 kg/m2 [2.2%; 95% CI, 0.009 to 0.021 kg/m2] more annual BMI gain, *P*FDR < .001) and, reciprocally, greater baseline BMI was linked specifically to more longitudinal withdrawn/depressed and depression problems (0.010 [22%; 95% CI, 0.004 to 0.016] and 0.011 [15%; 95% CI, 0.004 to 0.017] more problems annually per 1 kg/m2 above median BMI, *P*FDR = .003 and .008). The associations did not differ in boys vs. girls (*P*FDR ≥ .40), and remained stable with waist circumference as the weight index and in subgroups of participants without weight-altering medications or common baseline psychiatric diagnoses. Our longitudinal findings expand previous cross-sectional works and highlight the importance of cognitive and mental health to children’s weight development and links between weight and depression. ## Introduction High child and adolescent obesity rates (eg, 19.7% in the US) are problematic given links between early-life obesity and long-term health issues1. While evidence suggests cross-sectional associations between obesity, lower cognitive functioning, and worse mental health in youth2, it remains unclear whether these findings extend longitudinally and in what direction. Leveraging data from the large Adolescent Brain Cognitive Development (ABCD) Study (release 5.0)3,4, we examined how weight indices at ages 9-11 relate prospectively to changes in cognition and psychopathology across the 2 years thereafter, and vice versa. ## Methods Baseline (June 2016 to October 2018) and 1- and 2-year follow-up ABCD Study data collected pre-COVID-19 (March 13, 2020) were included for participants without severe medical conditions (**eMethods**). Weight indices (body mass index [BMI]; waist circumference [WC]) and psychopathology (Child Behavior Checklist) were assessed annually3; cognition (National Institutes of Health Toolbox Cognition Battery; Little Man Task of mental rotation; Rey Auditory Verbal Learning Test) was assessed at baseline and 2-year4 (**Table**). Caregivers and children provided written informed consent or assent to procedures approved by site institutional review boards. We followed the STROBE reporting guidelines. We used [age] × [baseline predictor] interactions in linear mixed models to estimate associations between baseline BMI or WC and changes in cognition or psychopathology across timepoints, and vice versa. Models also included lower-order main effects, sociodemographic and developmental covariates, random intercepts of participants within families within sites, and participant-level random slopes (except for cognition-as-outcome models limited by two timepoints) (Figure caption). Sensitivity analyses explored sex interactions and whether associations remained in children not using weight-related medications or without common baseline psychiatric diagnoses. ![Figure 1.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2023/12/15/2023.12.14.23299828/F1.medium.gif) [Figure 1.](http://medrxiv.org/content/early/2023/12/15/2023.12.14.23299828/F1) Figure 1. Associations between weight indices, cognition, and psychopathology as children enter adolescence Standardized β coefficients with 95% profile likelihood confidence intervals were longitudinal [age (centered at median baseline age of 10 y)] × [baseline BMI or WC] interactions (orange circles) or [age] × [baseline cognition or psychopathology] interactions (blue triangles), estimated in linear mixed models. Lower-order main effects were automatically added. Detailed statistics are shown in **eTables 1** (BMI) and **6** (WC), and unstandardized coefficients along with main effects of age are shown in **eTables 2** (BMI) and **7** (WC). Models used the BOBYQA optimizer with 100,000 maximum iterations. Fixed-effect covariates included child sex, area deprivation index national percentile, income-to-needs ratio, pubertal development scale total score, and familial history of mental illness (depression, mania, psychosis, suicide attempt, antisocial behavior) and drug or alcohol use problems. Random intercepts were participants nested within families within study sites. To capture heterogeneity in longitudinal changes, participant-level random slopes were included, except for models where cognition was the outcome and assessed only twice. Multiple comparison correction was performed within domains (cognition or psychopathology) and weight indices (BMI or WC) using false discovery rate (FDR) at two-tailed *P* ≤-.05. ADHD indicates attention-deficit/hyperactivity disorder; RAVLT, Rey Auditory Verbal Learning Test. View this table: [Table 1.](http://medrxiv.org/content/early/2023/12/15/2023.12.14.23299828/T1) Table 1. Participant characteristics ## Results Participant (n = 6671) characteristics are shown in **Table**. Baseline BMI was not associated with longitudinal changes in cognition (**Figure**; **eTable 1**), and this finding was not confounded by practice effects from repeated cognitive testing (**eMethods**). Conversely, lower baseline cognition was overall associated with greater longitudinal BMI gain. Unstandardized estimates indicated, eg, that children scoring 1 point lower on Picture Vocabulary at baseline had 0.012 kg/m2 (1.6%) more annual BMI gain than those scoring at the median (**eTable 2**). Higher baseline BMI was associated with more longitudinal withdrawn/depressed and depression problems (**Figure**; **eTable 1**), with each 1 kg/m2 increase corresponding to 0.010 (22%) and 0.011 (15%) more problems annually beyond changes at median BMI (**eTable 2**). On the other hand, greater baseline psychopathology was broadly associated with greater BMI gain. For instance, each baseline endorsement of externalizing and social problems corresponded to 0.015 kg/m2 (2.2%) and 0.038 kg/m2 (5.4%) more annual BMI increases compared to no endorsement. No interaction with sex was found in any analysis (**eTable 3**). Results remained consistent in subgroups of participants without weight-altering medications (**eTable 4**) or common baseline psychiatric diagnoses (**eTable 5**). Findings with WC were similar to those with BMI, except baseline internalizing spectrum did not predict longitudinal changes in WC (**eTables 6**-**10**). ## Supporting information eMethods; eTables 1-10; eFigures 1-2 [[supplements/299828_file02.docx]](pending:yes) ## Data Availability Data in this study were from the ABCD Release 5.0 (September 26, 2023; [https://doi.org/10.15154/8873-zj65](https://doi.org/10.15154/8873-zj65)). The ABCD Study repository grows and may be modified as new data are collected and processed. [https://doi.org/10.15154/8873-zj65](https://doi.org/10.15154/8873-zj65) ## Discussion Lower cognitive performance and greater broad-spectrum psychopathology were associated with increased weight gain as children entered adolescence. These factors have been linked to brain reward network dysfunction, impaired reward learning, and caregiver-child conflicts that potentially hamper adherence to healthy diet and lifestyle2,5,6. Reciprocally, higher weight was associated with more depression over time. Obesity may aggravate psychological stress via body dissatisfaction and weight-related discrimination, and also trigger inflammation-mediated hypothalamic-pituitary-adrenal axis dysregulation, both of which contribute to depression2,6. Together, our longitudinal results clarify previous cross-sectional findings and highlight the importance of cognitive and mental health to children’s weight development and links between weight and depression. Limitations include the limited longitudinal timeframe, inadequate executive function assessments, and lack of body composition measures. Future ABCD Study data and focused clinical cohorts can further delineate adolescent development, exploring late-emerging effects5, nonlinear trends, and biopsychosocial mediators. ## Author Contributions Mr. Li had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. *Concept and design*: Li, Ray, Hershey. *Acquisition, analysis, or interpretation of data*: All authors. *Drafting of the manuscript*: Li. *Critical revision of the manuscript for important intellectual content*: All authors. *Statistical analysis*: Li, Gu. *Obtained funding*: Hershey. *Supervision*: Hershey. ## Conflict of Interest Disclosures None reported. ## Funding/Support Mr. Li was supported by funding from the McDonnell Center for Systems Neuroscience at Washington University School of Medicine in St. Louis (allocated to Dr. Hershey for salary coverage for Mr. Li). Dr. Ray was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award KL2TR002346 and a National Institute of Diabetes and Digestive and Kidney Diseases K01 Career Development Award 1K01DK131339. Ms. Gu was supported by the Mallinckrodt Institute of Radiology summer research program. The ABCD Study is supported by grants U01DA041048, U01DA050989, U01DA051016, U01DA041022, U01DA051018, U01DA051037, U01DA050987, U01DA041174, U01DA041106, U01DA041117, U01DA041028, U01DA041134, U01DA050988, U01DA051039, U01DA041156, U01DA041025, U01DA041120, U01DA051038, U01DA041148, U01DA041093, U01DA041089, U24DA041123, and U24DA041147 from the National Institutes of Health and federal partners. A full list of supporters is available on the ABCD Study website ([https://abcdstudy.org/about/federal-partners](https://abcdstudy.org/about/federal-partners)). ## Role of the Funder/Sponsor The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. ## Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funders. ## Additional Contributions The authors thank Amjad Samara, MD (Department of Neurology, Washington University School of Medicine in St. Louis) for discussions about statistical analysis, for which financial compensation was not received. ## Additional Information Data in this study were from the ABCD Release 5.0 (September 26, 2023; [https://doi.org/10.15154/8873-zj65](https://doi.org/10.15154/8873-zj65)). The ABCD Study repository grows and may be modified as new data are collected and processed. * Received December 14, 2023. * Revision received December 14, 2023. * Accepted December 15, 2023. * © 2023, Posted by Cold Spring Harbor Laboratory This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/) ## References 1. 1.Hu K, Staiano AE. Trends in Obesity Prevalence Among Children and Adolescents Aged 2 to 19 Years in the US From 2011 to 2020. JAMA Pediatr. 2022;176(10):1037–1039. doi:10.1001/jamapediatrics.2022.2052 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jamapediatrics.2022.2052&link_type=DOI) 2. 2.Puder JJ, Munsch S. Psychological correlates of childhood obesity. Int J Obes. 2010;34(2):S37–S43. doi:10.1038/ijo.2010.238 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/ijo.2010.238&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21151145&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F12%2F15%2F2023.12.14.23299828.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000285286400006&link_type=ISI) 3. 3.Barch DM, Albaugh MD, Avenevoli S, et al. Demographic, physical and mental health assessments in the adolescent brain and cognitive development study: Rationale and description. Dev Cogn Neurosci. 2018;32:55–66. doi:10.1016/j.dcn.2017.10.010 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.dcn.2017.10.010&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=29113758&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F12%2F15%2F2023.12.14.23299828.atom) 4. 4.Luciana M, Bjork JM, Nagel BJ, et al. Adolescent neurocognitive development and impacts of substance use: Overview of the adolescent brain cognitive development (ABCD) baseline neurocognition battery. Dev Cogn Neurosci. 2018;32:67–79. doi:10.1016/j.dcn.2018.02.006 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.dcn.2018.02.006&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=29525452&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F12%2F15%2F2023.12.14.23299828.atom) 5. 5.Smith E, Hay P, Campbell L, Trollor JN. A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. Obes Rev. 2011;12(9):740–755. doi:10.1111/j.1467-789X.2011.00920.x [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/j.1467-789X.2011.00920.x&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21991597&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F12%2F15%2F2023.12.14.23299828.atom) 6. 6.Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies. Arch Gen Psychiatry. 2010;67(3):220–229. doi:10.1001/archgenpsychiatry.2010.2 [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/archgenpsychiatry.2010.2&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20194822&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F12%2F15%2F2023.12.14.23299828.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000275042900002&link_type=ISI)